|

ABBV-525 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • AbbVie1

Indications

  • B-cell Malignancies1
  • Chronic Lymphocytic Leukemia1
  • Non-Hodgkin's Lymphoma1
  • Diffuse Large B-Cell Lymphoma1
  • Cancer1

Los Angeles, California1 trial

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

University of California Los Angeles Medical Center /ID# 246357

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.